| Literature DB >> 30349449 |
Ying Zhang1, Yue-Xin Liu1, Qiu-Xia Xiao1, Qing Liu1, Rui Deng1, Jiang Bian1, Isaac Bul Deng2, Mohammed Al-Hawwas2, Feng-Xu Yu3.
Abstract
Postoperative cognitive dysfunction (POCD) is serious disorder in the central nervous system common in aged patients after anesthesia. Although its clinical symptoms are well recognized, however, the molecular etiology of the POCD remains unrevealed. Similarly, neither gold standard molecular diagnosis nor effective treatment is available for POCD until the present. Therefore, we aimed to explore the molecular mechanism of this disorder through investigating lncRNAs and mRNAs associated with POCD human patients and investigate their underlying regulatory pathways. In this study, we recruited 200 patients requiring hip or knee replacement surgery. Their neurological functions were assessed at two time points, 1 day before the surgery and 30 days post-surgery. In parallel, serum samples were collected from the participants to analyze lncRNAs and mRNAs differential expression profile between POCD and non-POCD patients using microarray analysis. To further investigate the role differentially expressed mRNA and lncRNAs, Gene Ontology (GO), pathway analyses on mRNAs and lncRNA-mRNA interaction network were performed. As a result, 68 lncRNAs and 115 mRNAs were dysregulated in the POCD group compared to non-POCD group. Among them, the top 10 upregulated lncRNAs and 10 downregulated lncRNAs were listed for enrichment analysis. Interestingly, we found that these lncRNA and mRNA are involved in biological process, molecular function, and cellular component in addition to various signaling pathways, suggesting that the pathogenesis of POCD involves lncRNAs and mRNAs differential expression. Consequently, the genetic dysregulation between the non-POCD and POCD patients participates in the occurrence and development of POCD, and could be served as diagnostic biomarkers and drug targets for POCD treatment.Entities:
Keywords: Gene Ontology; bioinformatics analysis; genetic dysregulation; lncRNA; mRNA; microarray analysis; postoperative cognitive dysfunction
Year: 2018 PMID: 30349449 PMCID: PMC6187303 DOI: 10.3389/fnins.2018.00694
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
General characteristics and cognitive functions of participants from study and control groups at baseline
| Item (baseline) | Study group ( | Control group ( | |
|---|---|---|---|
| Age (years) | 77.1 ± 2.5 | 77.3 ± 3.1 | 0.696 |
| Weight (kg) | 63.8 ± 10.7 | 65. 7 ± 12.4 | 0.380 |
| Education (years) | 8.3 ± 2.4 | 9.1 ± 2.6 | 0.096 |
| MMSE scores | 28.2 ± 1.6 | 28.8 ± 2.1 | 0.071 |
| DST scores | 16.3 ± 1.8 | 16.6 ± 1.6 | 0.392 |
| CDT scores | 2.5 ± 0.5 | 2.6 ± 0.6 | 0.326 |
| SDMT scores | 31.3 ± 3.2 | 30.4 ± 3.5 | 0.161 |
| TMT-A scores | 41.1 ± 5.8 | 42.4 ± 6.6 | 0.266 |
General characteristics, intraoperative indicators and cognitive functions of patients from non-POCD and POCD at baseline.
| Item (baseline) | Non-POCD ( | POCD ( | |
|---|---|---|---|
| Age (years) | 76.8 ± 2.7 | 77.2 ± 3.1 | 0.531 |
| Weight (kg) | 63.4 ± 11.2 | 64 ± 12.4 | 0.820 |
| Education (years) | 8.3 ± 1.4 | 8.6 ± 2.6 | 0.357 |
| ASA classification (I/II/III) | 32/104/24 | 5/14/2 | 0.501 |
| Operation time (min) | 84.9 ± 18.8 | 79.8 ± 19.6 | 0.246 |
| Intraoperative blood loss (ml) | 296.4 ± 37.2 | 290.6 ± 43.8 | 0.512 |
| Intraoperative urine output (ml) | 376.3 ± 86.2 | 370.4 ± 84.5 | 0.768 |
| Intraoperative blood sugar (mmol/l) | 5.71 ± 0.58 | 5.78 ± 0.66 | 0.610 |
| MMSE scores | 28.0 ± 1.4 | 28.4 ± 1.8 | 0.236 |
| DST scores | 16.1 ± 1.4 | 16.4 ± 1.5 | 0.361 |
| CDT scores | 2.4 ± 0.5 | 2.7 ± 0.6 | 0.013 |
| SDMT scores | 31.0 ± 3.6 | 31.6 ± 3.9 | 0.478 |
| TMT-A scores | 40.1 ± 7.8 | 42.3 ± 8.6 | 0.231 |
Neuropsychological test scores of non-POCD group and POCD group.
| Item | Non-POCD ( | POCD ( | |
|---|---|---|---|
| MMSE scores | 27.2 ± 0.6 | 25.9 ± 1.1 | 0.000 |
| DST scores | 14.1 ± 1.6 | 13.1 ± 1.1 | 0.006 |
| CDT scores | 2.3 ± 0.5 | 1.9 ± 0.7 | 0.001 |
| SDMT scores | 31.3 ± 3.2 | 28.9 ± 3.5 | 0.002 |
| TMT-A scores | 41.4 ± 5.1 | 38.7 ± 6.1 | 0.027 |